| High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis RA Moore, N Adel, E Riedel, M Bhutani, DR Feldman, NE Tabbara, G Soff, ... Journal of clinical oncology 29 (25), 3466-3473, 2011 | 492 | 2011 |
| Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myeloma N Korde, M Roschewski, A Zingone, M Kwok, EE Manasanch, M Bhutani, ... JAMA oncology 1 (6), 746-754, 2015 | 353 | 2015 |
| Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells AK Pathak, M Bhutani, AS Nair, KS Ahn, A Chakraborty, H Kadara, ... Molecular cancer research 5 (9), 943-955, 2007 | 309 | 2007 |
| Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool AK Pathak, M Bhutani, S Kumar, A Mohan, R Guleria Clinical chemistry 52 (10), 1833-1842, 2006 | 304 | 2006 |
| Capsaicin is a novel blocker of constitutive and interleukin-6–inducible STAT3 activation M Bhutani, AK Pathak, AS Nair, AB Kunnumakkara, S Guha, G Sethi, ... Clinical Cancer Research 13 (10), 3024-3032, 2007 | 252 | 2007 |
| Teclistamab, a B-cell maturation antigen× CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm … SZ Usmani, AL Garfall, NWCJ van de Donk, H Nahi, JF San-Miguel, ... The Lancet 398 (10301), 665-674, 2021 | 242 | 2021 |
| Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. V Raina, M Bhutani, R Bedi, A Sharma, SVS Deo, NK Shukia, BK Mohanti, ... Indian journal of cancer 42 (1), 2005 | 226 | 2005 |
| Extramedullary multiple myeloma M Bhutani, DM Foureau, S Atrash, PM Voorhees, SZ Usmani Leukemia 34 (1), 1-20, 2020 | 196 | 2020 |
| Kaposi sarcoma–associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment M Bhutani, MN Polizzotto, TS Uldrick, R Yarchoan Seminars in oncology 42 (2), 223-246, 2015 | 184 | 2015 |
| Effect of rhythmic breathing (Sudarshan Kriya and Pranayam) on immune functions and tobacco addiction V Kochupillai, P Kumar, D Singh, D Aggarwal, N Bhardwaj, M Bhutani, ... Annals of the New York Academy of Sciences 1056 (1), 242-252, 2005 | 153 | 2005 |
| A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma N Korde, M Carlsten, MJ Lee, A Minter, E Tan, M Kwok, E Manasanch, ... Haematologica 99 (6), e81, 2014 | 141 | 2014 |
| Chemotherapy Alone vs. Chemotherapy Plus High Dose Multiple Antioxidants in Patients with Advanced Non Small Cell Lung Cancer AK Pathak, M Bhutani, R Guleria, S Bal, A Mohan, BK Mohanti, A Sharma, ... Journal of the American College of Nutrition 24 (1), 16-21, 2005 | 139 | 2005 |
| Viral, immunologic, and clinical features of primary effusion lymphoma K Lurain, MN Polizzotto, K Aleman, M Bhutani, KM Wyvill, PH Gonçalves, ... Blood, The Journal of the American Society of Hematology 133 (16), 1753-1761, 2019 | 124 | 2019 |
| Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study BM Cherry, N Korde, M Kwok, EE Manasanch, M Bhutani, M Mulquin, ... Leukemia & lymphoma 54 (10), 2215-2218, 2013 | 116 | 2013 |
| Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib S Atrash, A Tullos, S Panozzo, M Bhutani, F Van Rhee, B Barlogie, ... Blood Cancer Journal 5 (1), e272-e272, 2015 | 115 | 2015 |
| Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases PR Tembhare, CM Yuan, D Venzon, R Braylan, N Korde, E Manasanch, ... Leukemia research 38 (3), 371-376, 2014 | 107 | 2014 |
| Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs M Bhutani, AK Pathak, YH Fan, DD Liu, JJ Lee, H Tang, JM Kurie, ... Cancer Prevention Research 1 (1), 39-44, 2008 | 106 | 2008 |
| Randomized trial comparing neo‐adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0‐2 M0) SVS Deo, M Bhutani, NK Shukla, V Raina, GK Rath, J Purkayasth Journal of surgical oncology 84 (4), 192-197, 2003 | 106 | 2003 |
| Lympho-hemopoietic malignancies in India M Bhutani, A Vora, L Kumar, V Kochupillai Medical Oncology 19, 141-150, 2002 | 93 | 2002 |
| Defining and treating high-risk multiple myeloma SZ Usmani, P Rodriguez-Otero, M Bhutani, MV Mateos, JS Miguel Leukemia 29 (11), 2119-2125, 2015 | 82 | 2015 |
